A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis

Clinical trial NCT06900192 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06900192
Sponsor: Stanford University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Progressive Multiple Sclerosis Multiple Sclerosis Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive

Start date: 2025-03-01
Primary completion: 2029-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.